Hussman Strategic Advisors, Inc. Aurinia Pharmaceuticals Inc. Transaction History
Hussman Strategic Advisors, Inc.
- $407 Million
- Q2 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 357,000 shares of AUPH stock, worth $4.06 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
357,000
Previous 210,000
70.0%
Holding current value
$4.06 Million
Previous $1.69 Million
79.09%
% of portfolio
0.74%
Previous 0.44%
Shares
2 transactions
Others Institutions Holding AUPH
# of Institutions
243Shares Held
66MCall Options Held
1.1MPut Options Held
772K-
Tang Capital Management LLC San Diego, CA10MShares$114 Million5.24% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$105 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5MShares$56.8 Million0.61% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$45.1 Million3.03% of portfolio
-
State Street Corp Boston, MA2.85MShares$32.4 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.61B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...